Michal Zikán

RAD51 135G→C Modifies Breast Cancer Risk among BRCA2 Mutation Carriers: Results from a Combined Analysis of 19 Studies

Antonis C. Antoniou, Olga M. Sinilnikova, Jacques Simard et al. · The American Journal of Human Genetics · 2007 · 243 citations · Full text

Medicine, Genetics, Oncology +16

Prognostic significance of low volume sentinel lymph node disease in early-stage cervical cancer

David Cibula, Nadeem R. Abu‐Rustum, Ladislav Dušek et al. · Gynecologic Oncology · 2011 · 222 citations

Medicine, Gynecology, Oncology +14

Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: Implications for Risk Prediction

Antonis C. Antoniou, Jonathan Beesley, Lesley McGuffog et al. · Cancer Research · 2010 · 184 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer

Martin Widschwendter, Michal Zikán, Benjamin Wahl et al. · Genome Medicine · 2017 · 175 citations · Full text

Medicine, Gynecology, Oncology +17

Association between the cervicovaginal microbiome, BRCA1 mutation status, and risk of ovarian cancer: a case-control study

Nuno R. Nené, Daniel Reisel, Andreas Leimbach et al. · The Lancet Oncology · 2019 · 158 citations · Full text

Medicine, Microbiology, Oncology +17